Your SlideShare is downloading. ×
New+Zealand+Diabetes+Care+Devices+Market+Outlook+to+2017-+Glucose+Monitoring+and+Insulin+Delivery
New+Zealand+Diabetes+Care+Devices+Market+Outlook+to+2017-+Glucose+Monitoring+and+Insulin+Delivery
New+Zealand+Diabetes+Care+Devices+Market+Outlook+to+2017-+Glucose+Monitoring+and+Insulin+Delivery
New+Zealand+Diabetes+Care+Devices+Market+Outlook+to+2017-+Glucose+Monitoring+and+Insulin+Delivery
New+Zealand+Diabetes+Care+Devices+Market+Outlook+to+2017-+Glucose+Monitoring+and+Insulin+Delivery
New+Zealand+Diabetes+Care+Devices+Market+Outlook+to+2017-+Glucose+Monitoring+and+Insulin+Delivery
New+Zealand+Diabetes+Care+Devices+Market+Outlook+to+2017-+Glucose+Monitoring+and+Insulin+Delivery
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

New+Zealand+Diabetes+Care+Devices+Market+Outlook+to+2017-+Glucose+Monitoring+and+Insulin+Delivery

122

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
122
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. New Zealand Diabetes Care Devices Market Outlook to 2017-Glucose Monitoring and Insulin DeliveryReport Details:Published:December 2011No. of Pages: 95Price: Single User License – US$2500Corporate User License – US$7500Report SummaryGlobalData’s new report, New Zealand Diabetes Care Devices Market Outlook to 2017- GlucoseMonitoring and Insulin Delivery provides key market data on the New Zealand Diabetes CareDevices market. The report provides value (USD million), volume (units) and average price (USD)data for each segment and sub-segment within two market categories – Glucose Monitoring andInsulin Delivery. The report also provides company shares and distribution shares data for each ofthe aforementioned market categories. The report is supplemented with global corporate-levelprofiles of the key market participants with information on company financials and pipelineproducts, wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope• Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.• 2010 company shares and distribution shares data for each of the two market categories.• Global corporate-level profiles of key companies operating within the New Zealand Diabetes Care Devicesmarket.• Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Abbott Laboratories, Medtronic, Inc., Bayer HealthCare AG, Novo Nordisk A/S and others.Reasons to buy• Develop business strategies by identifying the key market categories and segments poised for strong growth.• Develop market-entry and market expansion strategies.• Design competition strategies by identifying who-stands-where in the New Zealand Diabetes Care Devices competitive landscape.
  • 2. • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/144215-new-zealand-diabetes-care-devices-market-outlook-to-2017-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report includeTable of Contents1 Table of Contents 21.1 List of Tables 51.2 List of Figures 62 Introduction 82.1 What Is This Report About? 83 Diabetes Care Devices In New Zealand 93.1 Diabetes Care Devices, Market Segmentation 93.2 Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, 2003-2017 103.3 Diabetes Care Devices Market, New Zealand, Revenue Mix ($m), 2010 113.4 Diabetes Care Devices Market, New Zealand, Category Contribution (%), 2010 123.5 Diabetes Care Devices, New Zealand, Category Volume (Units), 2003-2017 193.6 Diabetes Care Devices, New Zealand, Company share (2009-2010) 244 Glucose Monitoring In New Zealand 264.1 Glucose Monitoring, Market Segmentation 264.2 Glucose Monitoring Market, New Zealand, Revenue Mix ($m), 2010 274.3 Glucose Monitoring Market, New Zealand, Segment Contribution (%), 2010 284.4 Glucose Monitoring Overall Revenue (2003-2017) 294.4.1 Blood Glucose Meters Revenue (2003-2017) 334.5 Glucose Monitoring Overall Volume (2003-2017) 374.5.1 Blood Glucose Meters Volume (2003-2017) 414.6 Glucose Monitoring Average Price (2003-2017) 454.7 Glucose Monitoring Distribution Share (2009-2010) 464.8 Glucose Monitoring, New Zealand, Company share (2009-2010) 475 Insulin Delivery In New Zealand 495.1 Insulin Delivery, Market Segmentation 495.2 Insulin Delivery Market, New Zealand, Revenue Mix ($m), 2010 50
  • 3. 5.3 Insulin Delivery Market, New Zealand, Segment Contribution (%), 2010 515.4 Insulin Delivery Overall Revenue (2003-2017) 525.4.1 Insulin Pens Revenue (2003-2017) 565.4.2 Insulin Pumps Revenue (2003-2017) 605.5 Insulin Delivery Overall Volume (2003-2017) 625.5.1 Insulin Pens Volume (2003-2017) 665.5.2 Insulin Pumps Volume (2003-2017) 705.6 Insulin Delivery Average Price (2003-2017) 725.7 Insulin Delivery Distribution Share (2009-2010) 735.8 Insulin Delivery, New Zealand, Company share (2009-2010) 746 Overview of Key Companies in New Zealand Diabetes Care Devices Market 766.1 F. Hoffmann-La Roche Ltd. 766.1.1 Company Overview 766.1.2 Share in the New Zealand Diabetes Care Devices Market 766.2 LifeScan, Inc. 776.2.1 Company Overview 776.2.2 Share in the New Zealand Diabetes Care Devices Market 776.3 Abbott Laboratories 786.3.1 Company Overview 786.3.2 Share in the New Zealand Diabetes Care Devices Market 786.4 Medtronic, Inc. 796.4.1 Company Overview 796.4.2 Share in the New Zealand Diabetes Care Devices Market 796.5 Bayer HealthCare AG 806.5.1 Company Overview 806.5.2 Share in the New Zealand Diabetes Care Devices Market 806.6 Novo Nordisk A/S 816.6.1 Company Overview 816.6.2 Share in the New Zealand Diabetes Care Devices Market 816.7 ARKRAY, Inc. 826.7.1 Company Overview 826.8 Sanofi 826.8.1 Company Overview 826.9 Eli Lilly and Company 826.9.1 Company Overview 826.10 Terumo Corporation 836.10.1 Company Overview 836.11 Animas Corporation 836.11.1 Company Overview 836.12 NIPRO CORPORATION 83
  • 4. 6.12.1 Company Overview 836.13 Becton, Dickinson and Company 846.13.1 Company Overview 847 Diabetes Care Devices Market Pipeline Products 858 Appendix 888.1 Definitions of Markets Covered in the Report 898.1.1 Diabetes Care Devices 898.2 Research Methodology 928.3 Secondary Research 928.4 Primary Research 938.5 Models 938.6 Forecasts 948.7 Expert Panels 948.8 GlobalData Consulting 948.9 Currency Conversion 958.10 Contact Us 958.11 Disclaimer 95List of TablesTable 1:Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, 2003-2017 10Table 2:Diabetes Care Devices Market, New Zealand, Category Contribution (%), 2010 12Table 3:Diabetes Care Devices, New Zealand, Cross-Segment Analysis, 2003-2017 14Table 4:Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, Historic, 2003-2010 16Table 5:Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, Forecast,2010-2017 18Table 6:Diabetes Care Devices, New Zealand, Category Volume (Units), 2003-2017 19Table 7:Diabetes Care Devices, New Zealand, Category Volume (Units), Historic, 2003-2010 21Table 8:Diabetes Care Devices, New Zealand, Category Volume (Units), Forecast, 2010-2017 23Table 9:Diabetes Care Devices, New Zealand, Company share by Revenue ($m), USD Actual,2009-2010 25Table 10:Glucose Monitoring Market, New Zealand, Segment Contribution (%), 2010 28Table 11:Glucose Monitoring, New Zealand, Revenue ($m), USD Actual by Segment, Historic,2003-2010 30Table 12:Glucose Monitoring, New Zealand, Revenue ($m), USD Actual by Segment, Forecast,2010-2017 32Table 13:Blood Glucose Meters, New Zealand, Revenue ($m), USD Actual by Sub-Segment,Historic, 2003-2010 34
  • 5. Table 14:Blood Glucose Meters, New Zealand, Revenue ($m), USD Actual by Sub-Segment,Forecast, 2010-2017 36Table 15:Glucose Monitoring, New Zealand, Volume (Units) by Segment, Historic, 2003-2010 38Table 16:Glucose Monitoring, New Zealand, Volume (Units) by Segment, Forecast, 2010-2017 40Table 17:Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Historic, 2003-2010 42Table 18:Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2010-2017 44Table 19:Glucose Monitoring, New Zealand, Average Price ($), Historic, 2003-2010 45Table 20:Glucose Monitoring, New Zealand, Average Price ($), Forecast, 2010-2017 45Table 21:Glucose Monitoring, New Zealand, Distribution Share by Revenue ($m), USD Actual,2009-2010 46Table 22:Glucose Monitoring, New Zealand, Company share by Revenue ($m), USD Actual 2009-2010 48Table 23:Insulin Delivery Market, New Zealand, Segment Contribution (%), 2010 51Table 24:Insulin Delivery, New Zealand, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 53Table 25:Insulin Delivery, New Zealand, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 55Table 26:Insulin Pens, New Zealand, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 57Table 27:Insulin Pens, New Zealand, Revenue ($m), USD Actual by Sub-Segment, Forecast,2010-2017 59Table 28:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Revenue ($m), USD Actual,Historic, 2003-2010 60Table 29:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Revenue ($m), USD Actual,Forecast, 2010-2017 61Table 30:Insulin Delivery, New Zealand, Volume (Units) by Segment, Historic, 2003-2010 63Table 31:Insulin Delivery, New Zealand, Volume (Units) by Segment, Forecast, 2010-2017 65Table 32:Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Historic, 2003-2010 67Table 33:Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69Table 34:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Volume (Units), Historic, 2003-2010 70Table 35:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Volume (Units), Forecast,2010-2017 71Table 36:Insulin Delivery, New Zealand, Average Price ($), Historic, 2003-2010 72Table 37:Insulin Delivery, New Zealand, Average Price ($), Forecast, 2010-2017 72Table 38:Insulin Delivery, New Zealand, Distribution Share by Revenue ($m), USD Actual, 2009-2010 73Table 39:Insulin Delivery, New Zealand, Company share by Revenue ($m), USD Actual 2009-2010 75
  • 6. Table 40:Diabetes Care Devices Market Pipeline Products 85Table 41: USD to Local Currency, New Zealand, Average Actual Rate 2003-2010 95List of FiguresFigure 1:Diabetes Care Devices, Market Segmentation 9Figure 2:Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, 2003-2017 10Figure 3:Diabetes Care Devices Market, New Zealand, Revenue Mix ($m), 2010 11Figure 4:Diabetes Care Devices Market, New Zealand, Category Contribution (%), 2010 12Figure 5:Diabetes Care Devices, New Zealand, Cross-Segment Analysis, 2003-2017 13Figure 6:Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, Historic,2003-2010 15Figure 7:Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, Forecast,2010-2017 17Figure 8:Diabetes Care Devices, New Zealand, Category Volume (Units), 2003-2017 19Figure 9:Diabetes Care Devices, New Zealand, Category Volume (Units), Historic, 2003-2010 20Figure 10:Diabetes Care Devices, New Zealand, Category Volume (Units), Forecast, 2010-201722Figure 11:Diabetes Care Devices, New Zealand, Company share (%), 2010 24Figure 12:Glucose Monitoring, Market Segmentation 26Figure 13:Glucose Monitoring Market, New Zealand, Revenue Mix ($m), 2010 27Figure 14:Glucose Monitoring Market, New Zealand, Segment Contribution (%), 2010 28Figure 15:Glucose Monitoring, New Zealand, Revenue ($m), USD Actual by Segment, Historic,2003-2010 29Figure 16:Glucose Monitoring, New Zealand, Revenue ($m), USD Actual by Segment, Forecast,2010-2017 31Figure 17:Blood Glucose Meters, New Zealand, Revenue ($m), USD Actual by Sub-Segment,Historic, 2003-2010 33Figure 18:Blood Glucose Meters, New Zealand, Revenue ($m), USD Actual by Sub-Segment,Forecast, 2010-2017 35Figure 19:Glucose Monitoring, New Zealand, Volume (Units) by Segment, Historic, 2003-2010 37Figure 20:Glucose Monitoring, New Zealand, Volume (Units) by Segment, Forecast, 2010-2017 39Figure 21:Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Historic, 2003-2010 41Figure 22:Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2010-2017 43Figure 23:Glucose Monitoring, New Zealand, Company share (%), 2010 47Figure 24:Insulin Delivery, Market Segmentation 49Figure 25:Insulin Delivery Market, New Zealand, Revenue Mix ($m), 2010 50Figure 26:Insulin Delivery Market, New Zealand, Segment Contribution (%), 2010 51Figure 27:Insulin Delivery, New Zealand, Revenue ($m), USD Actual by Segment, Historic, 2003-
  • 7. 2010 52Figure 28:Insulin Delivery, New Zealand, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 54Figure 29:Insulin Pens, New Zealand, Revenue ($m), USD Actual by Sub-Segment, Historic,2003-2010 56Figure 30:Insulin Pens, New Zealand, Revenue ($m), USD Actual by Sub-Segment, Forecast,2010-2017 58Figure 31:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Revenue ($m), USD Actual,Historic, 2003-2010 60Figure 32:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Revenue ($m), USD Actual,Forecast, 2010-2017 61Figure 33:Insulin Delivery, New Zealand, Volume (Units) by Segment, Historic, 2003-2010 62Figure 34:Insulin Delivery, New Zealand, Volume (Units) by Segment, Forecast, 2010-2017 64Figure 35:Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Historic, 2003-2010 66Figure 36:Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68Figure 37:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Volume (Units), Historic, 2003-2010 70Figure 38:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Volume (Units), Forecast,2010-2017 71Figure 39:Insulin Delivery, New Zealand, Company share (%), 2010 74Figure 40:F. Hoffmann-La Roche Ltd., Company Share (%),New Zealand Diabetes Care DevicesMarket, 2010 76Figure 41:LifeScan, Inc., Company Share (%),New Zealand Diabetes Care Devices Market, 201077Figure 42:Abbott Laboratories, Company Share (%),New Zealand Diabetes Care Devices Market,2010 78Figure 43:Medtronic, Inc., Company Share (%),New Zealand Diabetes Care Devices Market, 201079Figure 44:Bayer HealthCare AG, Company Share (%),New Zealand Diabetes Care DevicesMarket, 2010 80Figure 45:Novo Nordisk A/S., Company Share (%),New Zealand Diabetes Care Devices Market,2010 81Contact: sales@reportsandreports.com for more information.

×